Acasti Pharma (CVE:APO)

Acasti Pharma (CVE:APO)

Share Price
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Acasti Pharma

Acasti Pharma Inc. is a Canadian-based biopharmaceutical company dedicated in the research, development and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, bridging the treatment gap in lipid management. Acasti produces fi­rst-in-class and best-in-class anti-dyslipidemic...

Market: TSX-V:APO
Sector: Pharmaceuticals
col 3
col 4
col 5
col 6

Acasti Pharma Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use